- Home
- PCRX vs LILA Comparison
PCRX vs LILA Comparison
Compare PCRX & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- LILA
- Stock Information
- Founded
- PCRX 2006
- LILA 2017
- Country
- PCRX United States
- LILA Bermuda
- Employees
- PCRX N/A
- LILA N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- LILA Cable & Other Pay Television Services
- Sector
- PCRX Health Care
- LILA Telecommunications
- Exchange
- PCRX Nasdaq
- LILA Nasdaq
- Market Cap
- PCRX 1.2B
- LILA 1.1B
- IPO Year
- PCRX 2011
- LILA N/A
- Fundamental
- Price
- PCRX $24.10
- LILA $5.63
- Analyst Decision
- PCRX Buy
- LILA Sell
- Analyst Count
- PCRX 9
- LILA 1
- Target Price
- PCRX $29.89
- LILA $6.50
- AVG Volume (30 Days)
- PCRX 546.7K
- LILA 306.4K
- Earning Date
- PCRX 07-29-2025
- LILA 08-05-2025
- Dividend Yield
- PCRX N/A
- LILA N/A
- EPS Growth
- PCRX N/A
- LILA N/A
- EPS
- PCRX N/A
- LILA N/A
- Revenue
- PCRX $702,772,000.00
- LILA $4,441,000,000.00
- Revenue This Year
- PCRX $7.54
- LILA $2.45
- Revenue Next Year
- PCRX $10.78
- LILA $3.11
- P/E Ratio
- PCRX N/A
- LILA N/A
- Revenue Growth
- PCRX 3.08
- LILA N/A
- 52 Week Low
- PCRX $11.16
- LILA $4.26
- 52 Week High
- PCRX $29.61
- LILA $10.82
- Technical
- Relative Strength Index (RSI)
- PCRX 36.99
- LILA 60.99
- Support Level
- PCRX $23.99
- LILA $5.24
- Resistance Level
- PCRX $24.90
- LILA $5.59
- Average True Range (ATR)
- PCRX 0.88
- LILA 0.19
- MACD
- PCRX -0.21
- LILA 0.08
- Stochastic Oscillator
- PCRX 11.61
- LILA 88.65
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.